Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
June 10, 2002
INTERNATIONAL IMMUNIZATION NEWS
"Berna Drops Nasalflu Spray Linked to Facial Paralysis" Bloomberg Online (www.bloomberg.com) (06/06/02); Pfenniger, Chantal
Switzerland's Berna Biotech announced that it has ended its development of Nasalflu, an experimental inhaled influenza vaccine that has been linked with Bell's palsy, an illness that causes temporary facial paralysis. The company will halt its trial of some 11,000 patients after reviewing data collected from 4,000 of them, a move that is a tremendous blow to the firm. Not only will Berna miss out on continued development aid from Aventis, its partner in the Nasalflu venture, but Berna had billed itself as the company developing Nasalflu, so it will have to revamp its marketing strategies as well. Berna shares fell 16 percent to 24.4 Swiss francs, its biggest drop since listing publicly in June 2001, though its profit will not be impacted for 2002 because sales of the vaccine were small.
ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.